Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Neoplasms of the CNS

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 132 articles:
HTML format



Single Articles


    November 2020
  1. KIM JY, Kim HJ, Jung CW, Choi BI, et al
    PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III.
    Oncogene. 2020 Nov 13. pii: 10.1038/s41388-020-01543.
    PubMed     Abstract available


  2. TAN IL, Arifa RDN, Rallapalli H, Kana V, et al
    CSF1R inhibition depletes tumor-associated macrophages and attenuates tumor progression in a mouse sonic Hedgehog-Medulloblastoma model.
    Oncogene. 2020 Nov 6. pii: 10.1038/s41388-020-01536.
    PubMed     Abstract available


    October 2020
  3. ANGEL I, Pilo Kerman O, Rousso-Noori L, Friedmann-Morvinski D, et al
    Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01506.
    PubMed     Abstract available


  4. EUSTACE NJ, Anderson JC, Warram JM, Widden HN, et al
    A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.
    Oncogene. 2020 Oct 19. pii: 10.1038/s41388-020-01511.
    PubMed     Abstract available


  5. LATTIER JM, De A, Chen Z, Morales JE, et al
    Megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1) promotes glioblastoma cell invasion in the brain microenvironment.
    Oncogene. 2020 Oct 10. pii: 10.1038/s41388-020-01503.
    PubMed     Abstract available


  6. ANGOM RS, Mondal SK, Wang F, Madamsetty VS, et al
    Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme.
    Oncogene. 2020 Oct 1. pii: 10.1038/s41388-020-01462.
    PubMed     Abstract available


    September 2020
  7. MU M, Niu W, Zhang X, Hu S, et al
    LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
    Oncogene. 2020 Sep 25. pii: 10.1038/s41388-020-01466.
    PubMed     Abstract available


    August 2020
  8. YANG R, Zhao Y, Gu Y, Yang Y, et al
    Isocitrate dehydrogenase 1 mutation enhances 24(S)-hydroxycholesterol production and alters cholesterol homeostasis in glioma.
    Oncogene. 2020 Aug 27. pii: 10.1038/s41388-020-01439.
    PubMed     Abstract available


  9. LIU Y, Yang L, Liao F, Wang W, et al
    MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR.
    Oncogene. 2020 Aug 20. pii: 10.1038/s41388-020-01422.
    PubMed     Abstract available


  10. SABBAGH Q, Andre-Gregoire G, Guevel L, Gavard J, et al
    Vesiclemia: counting on extracellular vesicles for glioblastoma patients.
    Oncogene. 2020 Aug 14. pii: 10.1038/s41388-020-01420.
    PubMed     Abstract available


    July 2020
  11. XIA Q, Zhang H, Zhang P, Li Y, et al
    Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation.
    Oncogene. 2020 Jul 31. pii: 10.1038/s41388-020-01400.
    PubMed     Abstract available


    June 2020
  12. BOISSINOT M, King H, Adams M, Higgins J, et al
    Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300.
    Oncogene. 2020 Jun 17. pii: 10.1038/s41388-020-1360.
    PubMed     Abstract available


  13. AWAH CU, Chen L, Bansal M, Mahajan A, et al
    Ribosomal protein S11 influences glioma response to TOP2 poisons.
    Oncogene. 2020 Jun 11. pii: 10.1038/s41388-020-1342.
    PubMed     Abstract available


  14. YU S, Yu X, Sun L, Zheng Y, et al
    GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway.
    Oncogene. 2020 Jun 9. pii: 10.1038/s41388-020-1348.
    PubMed     Abstract available


    May 2020
  15. FENG J, Zhang Y, Ren X, Li D, et al
    Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide.
    Oncogene. 2020 May 5. pii: 10.1038/s41388-020-1312.
    PubMed     Abstract available


  16. SIMON T, Jackson E, Giamas G
    Breaking through the glioblastoma micro-environment via extracellular vesicles.
    Oncogene. 2020 May 4. pii: 10.1038/s41388-020-1308.
    PubMed     Abstract available


    April 2020
  17. ADAMSKI V, Hattermann K, Kubelt C, Cohrs G, et al
    Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1.
    Oncogene. 2020 Apr 28. pii: 10.1038/s41388-020-1302.
    PubMed     Abstract available


  18. LUCIA K, Wu Y, Garcia JM, Barlier A, et al
    Hypoxia and the hypoxia inducible factor 1alpha activate protein kinase A by repressing RII beta subunit transcription.
    Oncogene. 2020;39:3367-3380.
    PubMed     Abstract available


    March 2020
  19. GRASSI ES, Pantazopoulou V, Pietras A
    Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma.
    Oncogene. 2020 Mar 24. pii: 10.1038/s41388-020-1273.
    PubMed     Abstract available


    February 2020
  20. STRUVE N, Binder ZA, Stead LF, Brend T, et al
    EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastoma.
    Oncogene. 2020 Feb 17. pii: 10.1038/s41388-020-1208.
    PubMed     Abstract available


  21. YU Z, Feng J, Wang W, Deng Z, et al
    The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically.
    Oncogene. 2020 Feb 13. pii: 10.1038/s41388-020-1206.
    PubMed     Abstract available


  22. YANG R, Li X, Wu Y, Zhang G, et al
    EGFR activates GDH1 transcription to promote glutamine metabolism through MEK/ERK/ELK1 pathway in glioblastoma.
    Oncogene. 2020 Feb 7. pii: 10.1038/s41388-020-1199.
    PubMed     Abstract available


    January 2020
  23. NAERT T, Dimitrakopoulou D, Tulkens D, Demuynck S, et al
    RBL1 (p107) functions as tumor suppressor in glioblastoma and small-cell pancreatic neuroendocrine carcinoma in Xenopus tropicalis.
    Oncogene. 2020 Jan 30. pii: 10.1038/s41388-020-1173.
    PubMed     Abstract available


  24. RICCI B, Millner TO, Pomella N, Zhang X, et al
    Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma.
    Oncogene. 2020 Jan 27. pii: 10.1038/s41388-020-1161.
    PubMed     Abstract available


  25. GREEN AL, DeSisto J, Flannery P, Lemma R, et al
    Correction: BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.
    Oncogene. 2020 Jan 22. pii: 10.1038/s41388-020-1155.
    PubMed     Abstract available


    December 2019
  26. GREEN AL, DeSisto J, Flannery P, Lemma R, et al
    BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway.
    Oncogene. 2019 Dec 16. pii: 10.1038/s41388-019-1125.
    PubMed     Abstract available


  27. HERRMANN A, Lahtz C, Song J, Aftabizadeh M, et al
    Integrin alpha6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells.
    Oncogene. 2019 Dec 9. pii: 10.1038/s41388-019-1134.
    PubMed     Abstract available


    November 2019
  28. CHOBRUTSKIY BI, Yeagley M, Tipping P, Zaman S, et al
    Chemical complementarity between immune receptor CDR3s and IDH1 mutants correlates with increased survival for lower grade glioma.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1101.
    PubMed     Abstract available


  29. MANORANJAN B, Chokshi C, Venugopal C, Subapanditha M, et al
    A CD133-AKT-Wnt signaling axis drives glioblastoma brain tumor-initiating cells.
    Oncogene. 2019 Nov 6. pii: 10.1038/s41388-019-1086.
    PubMed     Abstract available


  30. ZHANG H, Zhu D, Zhang Z, Kaluz S, et al
    Correction: EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.
    Oncogene. 2019 Nov 1. pii: 10.1038/s41388-019-1067.
    PubMed     Abstract available


    October 2019
  31. NITTA RT, Bolin S, Luo E, Solow-Cordero DE, et al
    Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1077.
    PubMed     Abstract available


  32. JI J, Ding K, Luo T, Xu R, et al
    PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1.
    Oncogene. 2019 Oct 11. pii: 10.1038/s41388-019-1050.
    PubMed     Abstract available


  33. YANG W, Li Y, Gao R, Xiu Z, et al
    MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/beta-catenin signaling pathway.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1045.
    PubMed     Abstract available


  34. ZHANG H, Zhu D, Zhang Z, Kaluz S, et al
    EZH2 targeting reduces medulloblastoma growth through epigenetic reactivation of the BAI1/p53 tumor suppressor pathway.
    Oncogene. 2019 Oct 3. pii: 10.1038/s41388-019-1036.
    PubMed     Abstract available


    September 2019
  35. LI D, Tian Y, Hu Y, Qi Y, et al
    Correction: Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9.
    Oncogene. 2019 Sep 19. pii: 10.1038/s41388-019-1018.
    PubMed     Abstract available


  36. QIAN M, Wang S, Guo X, Wang J, et al
    Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-kappaB pathways.
    Oncogene. 2019 Sep 4. pii: 10.1038/s41388-019-0996.
    PubMed     Abstract available


  37. LI Y, Li W, Zeng X, Tang X, et al
    The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma.
    Oncogene. 2019 Sep 2. pii: 10.1038/s41388-019-0922.
    PubMed     Abstract available


    August 2019
  38. SIRKISOON SR, Carpenter RL, Rimkus T, Doheny D, et al
    TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
    Oncogene. 2019 Aug 28. pii: 10.1038/s41388-019-0959.
    PubMed     Abstract available


  39. POLONEN P, Jawahar Deen A, Leinonen HM, Jyrkkanen HK, et al
    Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma.
    Oncogene. 2019 Aug 23. pii: 10.1038/s41388-019-0956.
    PubMed     Abstract available


  40. SON B, Lee S, Kim H, Kang H, et al
    Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma.
    Oncogene. 2019 Aug 23. pii: 10.1038/s41388-019-0974.
    PubMed     Abstract available


  41. LIU Y, Li X, Zhang Y, Wang H, et al
    An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
    Oncogene. 2019 Aug 19. pii: 10.1038/s41388-019-0952.
    PubMed     Abstract available


  42. NITTA RT, Bolin S, Luo E, Solow-Codero DE, et al
    Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.
    Oncogene. 2019 Aug 12. pii: 10.1038/s41388-019-0927.
    PubMed     Abstract available


  43. THAKUR VS, Aguila B, Brett-Morris A, Creighton CJ, et al
    Spermidine/spermine N1-acetyltransferase 1 is a gene-specific transcriptional regulator that drives brain tumor aggressiveness.
    Oncogene. 2019 Aug 9. pii: 10.1038/s41388-019-0917.
    PubMed     Abstract available


  44. LI D, Tian Y, Hu Y, Qi Y, et al
    Glioma-associated human endothelial cell-derived extracellular vesicles specifically promote the tumourigenicity of glioma stem cells via CD9.
    Oncogene. 2019 Aug 9. pii: 10.1038/s41388-019-0903.
    PubMed     Abstract available


  45. KIM EH, Jo Y, Sai S, Park MJ, et al
    Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.
    Oncogene. 2019 Aug 2. pii: 10.1038/s41388-019-0882.
    PubMed     Abstract available


    July 2019
  46. DING K, Ji J, Zhang X, Huang B, et al
    RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
    Oncogene. 2019 Jul 22. pii: 10.1038/s41388-019-0888.
    PubMed     Abstract available


  47. SILVA-EVANGELISTA C, Barret E, Menez V, Merlevede J, et al
    A kinome-wide shRNA screen uncovers vaccinia-related kinase 3 (VRK3) as an essential gene for diffuse intrinsic pontine glioma survival.
    Oncogene. 2019 Jul 19. pii: 10.1038/s41388-019-0884.
    PubMed     Abstract available


  48. CORDERO A, Kanojia D, Miska J, Panek WK, et al
    FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis.
    Oncogene. 2019 Jul 19. pii: 10.1038/s41388-019-0893.
    PubMed     Abstract available


  49. SUN B, Zhao X, Ming J, Liu X, et al
    Stepwise detection and evaluation reveal miR-10b and miR-222 as a remarkable prognostic pair for glioblastoma.
    Oncogene. 2019 Jul 9. pii: 10.1038/s41388-019-0867.
    PubMed     Abstract available


  50. TOTSCH SK, Schlappi C, Kang KD, Ishizuka AS, et al
    Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance.
    Oncogene. 2019 Jul 9. pii: 10.1038/s41388-019-0870.
    PubMed     Abstract available


  51. BARRY S, Carlsen E, Marques P, Stiles CE, et al
    Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors.
    Oncogene. 2019;38:5381-5395.
    PubMed     Abstract available


    May 2019
  52. TEW BY, Legendre C, Gooden GC, Johnson KN, et al
    Isolation and characterization of patient-derived CNS metastasis-associated stromal cell lines.
    Oncogene. 2019;38:4002-4014.
    PubMed     Abstract available


  53. WILLIAMS KC, Cepeda MA, Javed S, Searle K, et al
    Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis.
    Oncogene. 2019;38:3598-3615.
    PubMed     Abstract available


    April 2019
  54. FADHLULLAH SFB, Halim NBA, Yeo JYT, Ho RLY, et al
    Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.
    Oncogene. 2019 Apr 9. pii: 10.1038/s41388-019-0809.
    PubMed     Abstract available


    February 2019
  55. CONTRERAS-ZARATE MJ, Day NL, Ormond DR, Borges VF, et al
    Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases.
    Oncogene. 2019 Feb 22. pii: 10.1038/s41388-019-0756.
    PubMed     Abstract available


  56. ALESSANDRINI F, Menotti L, Avitabile E, Appolloni I, et al
    Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model.
    Oncogene. 2019 Feb 12. pii: 10.1038/s41388-019-0737.
    PubMed     Abstract available


    January 2019
  57. CHU Y, Elrod N, Wang C, Li L, et al
    Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Oncogene. 2019 Jan 31. pii: 10.1038/s41388-019-0714.
    PubMed     Abstract available


    December 2018
  58. CUI T, Bell EH, McElroy J, Becker AP, et al
    miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma.
    Oncogene. 2018 Dec 17. pii: 10.1038/s41388-018-0601.
    PubMed     Abstract available


  59. NIE E, Miao F, Jin X, Wu W, et al
    Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.
    Oncogene. 2018 Dec 12. pii: 10.1038/s41388-018-0596.
    PubMed     Abstract available


  60. ZHANG L, Cheng F, Wei Y, Zhang L, et al
    Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells.
    Oncogene. 2018 Dec 12. pii: 10.1038/s41388-018-0626.
    PubMed     Abstract available


    October 2018
  61. LIU Y, Li F, Yang YT, Xu XD, et al
    IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
    Oncogene. 2018 Oct 27. pii: 10.1038/s41388-018-0525.
    PubMed     Abstract available


  62. ZEPECKI JP, Snyder KM, Moreno MM, Fajardo E, et al
    Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0546.
    PubMed     Abstract available


  63. BAKHSHINYAN D, Venugopal C, Adile AA, Garg N, et al
    BMI1 is a therapeutic target in recurrent medulloblastoma.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0549.
    PubMed     Abstract available


  64. LIU X, Bao Y, Meng W, Yang P, et al
    TROY interacts with RKIP to promote glioma development.
    Oncogene. 2018 Oct 18. pii: 10.1038/s41388-018-0503.
    PubMed     Abstract available


    September 2018
  65. CHEN T, Chen J, Zhu Y, Li Y, et al
    CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
    Oncogene. 2018 Sep 26. pii: 10.1038/s41388-018-0515.
    PubMed     Abstract available


  66. NEUBAUER HA, Tea MN, Zebol JR, Gliddon BL, et al
    Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0504.
    PubMed     Abstract available


    August 2018
  67. TAN Z, Song L, Wu W, Zhou Y, et al
    Correction: TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2.
    Oncogene. 2018 Aug 29. pii: 10.1038/s41388-018-0467.
    PubMed     Abstract available


  68. WILLEMS E, Dedobbeleer M, Digregorio M, Lombard A, et al
    Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0437.
    PubMed     Abstract available


  69. LIU Z, Wei Y, Zhang L, Yee PP, et al
    Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0425.
    PubMed     Abstract available


  70. FENG J, Zhang Y, She X, Sun Y, et al
    Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1alpha stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0423.
    PubMed     Abstract available


    July 2018
  71. KAVERINA NV, Kadagidze ZG, Borovjagin AV, Karseladze AI, et al
    Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.
    Oncogene. 2018 Jul 10. pii: 10.1038/s41388-018-0395.
    PubMed     Abstract available


    June 2018
  72. YU OM, Benitez JA, Plouffe SW, Ryback D, et al
    YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.
    Oncogene. 2018 Jun 11. pii: 10.1038/s41388-018-0301.
    PubMed     Abstract available


  73. TAN Z, Song L, Wu W, Zhou Y, et al
    TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2.
    Oncogene. 2018 Jun 4. pii: 10.1038/s41388-018-0344.
    PubMed     Abstract available


  74. YOO KC, Suh Y, An Y, Lee HJ, et al
    Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.
    Oncogene. 2018;37:3317-3328.
    PubMed     Abstract available


    May 2018
  75. BOETTO J, Apra C, Bielle F, Peyre M, et al
    Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0328.
    PubMed     Abstract available


  76. YU M, Li W, Wang Q, Wang Y, et al
    Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0319.
    PubMed     Abstract available


  77. ZHOU X, Li G, An S, Li WX, et al
    A new method of identifying glioblastoma subtypes and creation of corresponding animal models.
    Oncogene. 2018 May 17. pii: 10.1038/s41388-018-0305.
    PubMed     Abstract available


  78. LI N, Zhang Y, Sidlauskas K, Ellis M, et al
    Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0277.
    PubMed     Abstract available


  79. GUO X, Qiu W, Liu Q, Qian M, et al
    Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0261.
    PubMed     Abstract available


    April 2018
  80. HEUKERS R, Fan TS, de Wit RH, van Senten JR, et al
    The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0255.
    PubMed     Abstract available


  81. BEGUM S, Yiu A, Stebbing J, Castellano L, et al
    Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0230.
    PubMed     Abstract available


  82. LU J, Liu L, Zheng M, Li X, et al
    MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0249.
    PubMed     Abstract available


    March 2018
  83. JIN P, Shin SH, Chun YS, Shin HW, et al
    Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-kappaB signaling pathway.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0182.
    PubMed     Abstract available


  84. LIU YY, Chen MB, Cheng L, Zhang ZQ, et al
    microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation.
    Oncogene. 2018 Mar 9. pii: 10.1038/s41388-018-0184.
    PubMed     Abstract available


  85. ZHU ZC, Liu JW, Li K, Zheng J, et al
    KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
    Oncogene. 2018 Mar 9. pii: 10.1038/s41388-018-0180.
    PubMed     Abstract available


  86. BOLIN S, Borgenvik A, Persson CU, Sundstrom A, et al
    Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0135.
    PubMed     Abstract available


    February 2018
  87. OYINLADE O, Wei S, Lal B, Laterra J, et al
    Targeting UDP-alpha-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.
    Oncogene. 2018 Feb 26. pii: 10.1038/s41388-018-0138.
    PubMed     Abstract available


  88. CAJA L, Tzavlaki K, Dadras MS, Tan EJ, et al
    Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0136.
    PubMed     Abstract available


  89. SIRKISOON SR, Carpenter RL, Rimkus T, Anderson A, et al
    Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0132.
    PubMed     Abstract available


    January 2018
  90. ZHANG M, Huang N, Yang X, Luo J, et al
    A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0019.
    PubMed     Abstract available


  91. SUN L, Yu S, Xu H, Zheng Y, et al
    FHL2 interacts with EGFR to promote glioblastoma growth.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0068.
    PubMed     Abstract available


  92. LOSKUTOV YV, Griffin CL, Marinak KM, Bobko A, et al
    LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0049.
    PubMed     Abstract available


  93. AN Z, Aksoy O, Zheng T, Fan QW, et al
    Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0045.
    PubMed     Abstract available


    December 2017
  94. BOUSSIOTIS VA, Charest A
    Immunotherapies for malignant glioma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0024.
    PubMed     Abstract available


    November 2017
  95. ALMIRON BONNIN DA, Havrda MC, Lee MC, Liu H, et al
    Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
    Oncogene. 2017 Nov 20. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  96. PROVENZANO L, Ryan Y, Hilton DA, Lyons-Rimmer J, et al
    Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.
    Oncogene. 2017;36:6132-6142.
    PubMed     Abstract available


    October 2017
  97. HOLMES B, Benavides-Serrato A, Freeman RS, Landon KA, et al
    mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  98. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
    Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  99. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  100. CHEN D, Fan Z, Rauh M, Buchfelder M, et al
    ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Oncogene. 2017;36:5593-5608.
    PubMed     Abstract available


    September 2017
  101. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  102. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
    DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    August 2017
  103. JAIN P, Fierst TM, Han HJ, Smith TE, et al
    CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  104. GUERRERO PA, Tchaicha JH, Chen Z, Morales JE, et al
    Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    July 2017
  105. YAN D, Kowal J, Akkari L, Schuhmacher AJ, et al
    Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  106. TAYLOR E, Alqadri N, Dodgson L, Mason D, et al
    MRL proteins cooperate with activated Ras in glia to drive distinct oncogenic outcomes.
    Oncogene. 2017;36:4311-4322.
    PubMed     Abstract available


  107. RODRIGUEZ-BLANCO J, Pednekar L, Penas C, Li B, et al
    Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  108. ARSLAN AD, Sassano A, Saleiro D, Lisowski P, et al
    Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
    Oncogene. 2017 Jul 3. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    June 2017
  109. YANG JM, Schiapparelli P, Nguyen HN, Igarashi A, et al
    Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
    Oncogene. 2017;36:3673-3685.
    PubMed     Abstract available


  110. CASTRO BA, Flanigan P, Jahangiri A, Hoffman D, et al
    Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Oncogene. 2017;36:3749-3759.
    PubMed     Abstract available


  111. CONDUIT SE, Ramaswamy V, Remke M, Watkins DN, et al
    A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  112. TIAN R, Wang J, Yan H, Wu J, et al
    Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    May 2017
  113. KESANAKURTI D, Maddirela D, Banasavadi-Siddegowda YK, Lai TH, et al
    A novel interaction of PAK4 with PPARgamma to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2016.
    PubMed     Abstract available


  114. ZHU C, Chrifi I, Mustafa D, van der Weiden M, et al
    CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  115. ZENG AL, Yan W, Liu YW, Wang Z, et al
    Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  116. KAWAUCHI D, Ogg RJ, Liu L, Shih DJH, et al
    Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  117. WALD JH, Hatakeyama J, Printsev I, Cuevas A, et al
    Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  118. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  119. LIU YS, Lin HY, Lai SW, Huang CY, et al
    MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    April 2017
  120. SCHROCK MS, Batar B, Lee J, Druck T, et al
    Wwox-Brca1 interaction: role in DNA repair pathway choice.
    Oncogene. 2017;36:2215-2227.
    PubMed     Abstract available


  121. NANDHU MS, Kwiatkowska A, Bhaskaran V, Hayes J, et al
    Tumor-derived fibulin-3 activates pro-invasive NF-kappaB signaling in glioblastoma cells and their microenvironment.
    Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  122. HU PS, Xia QS, Wu F, Li DK, et al
    NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  123. DEGUCHI S, Katsushima K, Hatanaka A, Shinjo K, et al
    Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  124. QI Q, Kang SS, Zhang S, Pham C, et al
    Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  125. SHIN CH, Robinson JP, Sonnen JA, Welker AE, et al
    HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    February 2017
  126. NATSUME A, Kato T, Kinjo S, Enomoto A, et al
    Girdin maintains the stemness of glioblastoma stem cells.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.
    PubMed    


  127. CHEN R, Duan J, Li L, Ma Q, et al
    mTOR promotes pituitary tumor development through activation of PTTG1.
    Oncogene. 2017;36:979-988.
    PubMed     Abstract available


  128. MASILAMANI AP, Ferrarese R, Kling E, Thudi NK, et al
    KLF6 depletion promotes NF-kappaB signaling in glioblastoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Abstract available


    December 2016
  129. VOLPIN F, Casaos J, Sesen J, Mangraviti A, et al
    Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Abstract available


    November 2016
  130. SAREDDY GR, Viswanadhapalli S, Surapaneni P, Suzuki T, et al
    Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Abstract available


    October 2016
  131. GARG N, Bakhshinyan D, Venugopal C, Mahendram S, et al
    CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Abstract available


    September 2016
  132. TALAMILLO A, Grande L, Ruiz-Ontanon P, Velasquez C, et al
    ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: